Cite
HARVARD Citation
Appelbaum, J. et al. (n.d.). 100 Drug-regulatable engineered T cells eliminate CD33+ and CD33ΔE2+ AML. Journal for immunotherapy of cancer. p. A63. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Appelbaum, J. et al. (n.d.). 100 Drug-regulatable engineered T cells eliminate CD33+ and CD33ΔE2+ AML. Journal for immunotherapy of cancer. p. A63. [Online].